[1]
Kaul, V. et al. 2016. An open label study on Depression Patient’s Disability Outcomes: Comparative Evaluation of Escitalopram and Amisulpride. Journal of Nobel Medical College. 5, 2 (Dec. 2016), 37–42. DOI:https://doi.org/10.3126/jonmc.v5i2.16315.